Exploring the Distinctiveness of Restylane Contour Filler
These days, there is undoubtedly an abundance of diverse hyaluronic acid fillers available, offering numerous choices for every area of the face. However, the newly introduced Restylane Contour presents some exceptional and remarkable disparities.
It has gained approval from the U.S. Food and Drug Administration (FDA) for cheek augmentation, a procedure that has been in the spotlight recently – cheek filler searches rose by 218% between 2018 and 2024 (as stated by Galderma, the producers of the Restylane family of fillers). On RealSelf, dermal fillers were among the most discussed procedures by consumers and providers in 2024. “Cheeks are the foundation of the face, and concentrating on the natural contour rather than just volume loss can lead to a dynamic expression that enhances their natural charm,” remarks Dr. Leslie Baumann, a board-certified dermatologist in Miami and a lead researcher in the clinical trial of Restylane Contour. “The levels of hyaluronic acid in the skin decline as we age, causing the face to lose its form and increasing the probability of wrinkles and folds emerging.”
Whereas previous fillers might sometimes make the cheek area appear rigid and immobile, Restylane Contour distinguishes itself through the use of the brand's XpressHAn Technology. Already present in the company's Restylane Kysse and Restylane Defyne fillers – utilized for the lips and lower face/chin respectively – this is the first filler option for cheeks to employ it.
So, what exactly is it? In a nutshell, it's Restylane's exclusive method of manufacturing the filler, creating a supple and smooth gel that integrates better into the skin, enabling it to move as your face does. This not only results in a more natural-looking contour of the cheeks – especially during movement – but might also imply that ultimately less filler is necessary. In the FDA study, patients treated with Restylane Contour actually required a lower total volume to achieve their ideal results compared to a competing product. These outcomes can also persist for up to a year; in the same study, 96% of patients remained content with the appearance of their cheeks one year after injection.
